Literature DB >> 8027254

Thyroid hormone potentiates the antiviral action of interferon-gamma in cultured human cells.

H Y Lin1, H R Thacore, P J Davis, F B Davis.   

Abstract

Human interferon-gamma (hIFN gamma) exhibits a number of biological effects, including antiviral activity in homologous cells. The antiviral activity of recombinant (r) hIFN gamma, estimated by inhibition of vesicular stomatitis virus yield, was potentiated up to 120-fold in human fibroblast (BG-9) cells exposed to free L-T4 (0.5 x 10(-10) mol/L). Thyroid hormone alone did not induce the antiviral state in BG-9 cells. L-T3 also potentiated the antiviral action of rhIFN gamma, but D-T4 and D-T3 were ineffective. The antiviral effect of hIFN alpha in BG-9 cells was not influenced by thyroid hormone. Exposure of rhIFN gamma-treated BG-9 cells to L-T4 for only 3 h was sufficient to potentiate hIFN gamma-mediated antiviral activity. Similar potentiation by L-T4 of the antiviral effect of rhIFN gamma in HeLa cell cultures was also observed. Although the mechanism of potentiation of rhIFN gamma action by thyroid hormone is incompletely understood, the absence of antiviral activity of thyroid hormone alone indicates that the iodothyronine effect does not depend upon hormonal action on genes able to be stimulated by IFN gamma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027254     DOI: 10.1210/jcem.79.1.8027254

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Thyroid hormone promotes the phosphorylation of STAT3 and potentiates the action of epidermal growth factor in cultured cells.

Authors:  H Y Lin; A Shih; F B Davis; P J Davis
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

2.  Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study.

Authors:  Huy A Tran; Tracey L Jones; Robert Gibson; Glenn Em Reeves
Journal:  BMC Endocr Disord       Date:  2011-05-24       Impact factor: 2.763

3.  The reduced predictive value of interleukin 28b gene polymorphisms in a cohort of patients with thyroiditis developed during antiviral therapy for chronic hepatitis C: a preliminary study.

Authors:  Huy A Tran; Tracey L Jones; Elizabeth A Ianna; Robert A Gibson; Glenn E M Reeves
Journal:  Hepat Mon       Date:  2012-08-30       Impact factor: 0.660

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.